Cargando…

A timely update of global COVID-19 vaccine development

This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klavinskis, Linda S., Liu, Margaret A., Lu, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Article Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605319/ https://www.ncbi.nlm.nih.gov/pubmed/33059515 http://dx.doi.org/10.1080/22221751.2020.1838246

Ejemplares similares

EV71 vaccines: a milestone in the history of global vaccine development
por: Lu, Shan
Publicado: (2014)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

The Time for COVID-19 Vaccination
por: Domingo, Esteban, et al.
Publicado: (2021)

A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective
por: Al-Qahtani, Wedad Saeed, et al.
Publicado: (2021)

Global COVID-19 vaccine inequity: The scope, the impact, and the challenges
por: Asundi, Archana, et al.
Publicado: (2021)

Global impacts of COVID-19 on sustainable ocean development
por: Jiang, Qutu, et al.
Publicado: (2022)

The global fight to develop antipoverty vaccines in the anti-vaccine era
por: Hotez, Peter J.
Publicado: (2018)

Achieving path-dependent equity for global COVID-19 vaccine allocation
por: So, Anthony D., et al.
Publicado: (2021)

Sanctioned countries in the global COVID-19 vaccination campaign: the forgotten 70%
por: Blanchet, Karl, et al.
Publicado: (2021)

Flashing red lights: the global implications of COVID-19 vaccination passports
por: Voigt, Kristin, et al.
Publicado: (2021)

COVID-19 pandemic-induced physical inactivity: the necessity of updating the Global Action Plan on Physical Activity 2018-2030
por: Amini, H., et al.
Publicado: (2021)

Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response
por: Ruscio, Bruce A., et al.
Publicado: (2020)

Prisons need to be included in global and national vaccinations effort against COVID-19
por: Neufeld, Maria, et al.
Publicado: (2021)

Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
por: Naniche, Denise, et al.
Publicado: (2021)

COVID‐19 and the heart: An update for clinicians
por: Goha, Ahmed, et al.
Publicado: (2020)

Contemplating HPV vaccination in Japan during the time of COVID-19
por: Miyoshi, Ai, et al.
Publicado: (2020)

Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
por: Berges, Maja, et al.
Publicado: (2022)

How to ensure we can track and trace global use of COVID-19 vaccines?
por: Vander Stichele, Robert H., et al.
Publicado: (2021)

Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind
por: Heidari, Shirin, et al.
Publicado: (2021)

Developing standard safety outcomes for COVID-19 vaccines
por: Buttery, Jim P.
Publicado: (2021)

COVID-19: time for paradigm shift in the nexus between local, national and global health
por: Paul, Elisabeth, et al.
Publicado: (2020)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022)

Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
por: Gleeson, Deborah, et al.
Publicado: (2022)

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
por: Krause, Philip R, et al.
Publicado: (2022)

The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19
por: McAteer, John, et al.
Publicado: (2020)

India’s cost-effective COVID-19 vaccine development initiatives
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Advances in skin science enable the development of a COVID-19 vaccine
por: Falo, Louis D.
Publicado: (2020)

COVID-19: Coronavirus Vaccine Development Updates
por: Zhao, Jing, et al.
Publicado: (2020)

The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
por: Burgos, Rodrigo M, et al.
Publicado: (2021)

Ethical Considerations in Chemotherapy and Vaccines in Cancer Patients in Times of the COVID-19 Pandemic
por: Schiappacasse, Guido V.
Publicado: (2021)

Rethinking COVID-19 vaccine allocation: it is time to care about our neighbours
por: Contreras, Sebastian, et al.
Publicado: (2021)

Need of Vibrant Vaccine Pharmacovigilance During Current Global COVID-19 Pandemic: More Than Ever
por: Meher, Bikash Ranjan
Publicado: (2021)

Update on possible animal sources for COVID‐19 in humans
por: Opriessnig, Tanja, et al.
Publicado: (2020)

An update to “novel therapeutic approaches for treatment of COVID-19”
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics
por: Su, Shan, et al.
Publicado: (2021)

Dietary and health biomarkers—time for an update
por: Dragsted, Lars O., et al.
Publicado: (2017)

The development of COVID-19 vaccines in the United States: Why and how so fast?
por: Kuter, Barbara J., et al.
Publicado: (2021)

An update on the global vaccine development for coronavirus()
por: Rab, Shanay, et al.
Publicado: (2020)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together
por: Rackimuthu, Sudhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmmugnfec0t0r3nmmlfjmu0uiv